1. Home
  2. ARVN vs GOGO Comparison

ARVN vs GOGO Comparison

Compare ARVN & GOGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$7.57

Market Cap

658.2M

Sector

Health Care

ML Signal

HOLD

Logo Gogo Inc.

GOGO

Gogo Inc.

HOLD

Current Price

$3.56

Market Cap

566.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARVN
GOGO
Founded
2015
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
658.2M
566.2M
IPO Year
2018
2011

Fundamental Metrics

Financial Performance
Metric
ARVN
GOGO
Price
$7.57
$3.56
Analyst Decision
Buy
Hold
Analyst Count
19
2
Target Price
$15.05
$15.00
AVG Volume (30 Days)
694.3K
1.7M
Earning Date
05-04-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
58.84
N/A
EPS
N/A
0.10
Revenue
$262,600,000.00
$910,491,000.00
Revenue This Year
N/A
$3.68
Revenue Next Year
N/A
$3.60
P/E Ratio
N/A
$35.90
Revenue Growth
N/A
104.74
52 Week Low
$6.06
$3.29
52 Week High
$14.22
$16.82

Technical Indicators

Market Signals
Indicator
ARVN
GOGO
Relative Strength Index (RSI) 37.96 38.55
Support Level $7.35 $3.29
Resistance Level $10.18 $4.92
Average True Range (ATR) 0.42 0.29
MACD 0.05 -0.04
Stochastic Oscillator 31.43 17.19

Price Performance

Historical Comparison
ARVN
GOGO

About ARVN Arvinas Inc.

Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.

About GOGO Gogo Inc.

Gogo Inc is a broadband connectivity service for the business aviation market. It provides a customizable suite of smart cabin systems for integrated connectivity, inflight entertainment, and voice solutions. Its business segment includes Gogo BA and Satcom Direct. It generates two types of revenue: service revenue consists of monthly subscription and usage fees paid by aircraft owners and operators for telecommunication, data, and in-flight entertainment services, and equipment revenue consists of proceeds from the sale of ATG and narrowband satellite connectivity equipment and is recognized when control of the equipment is transferred to OEMs and dealers, which generally occurs when the equipment is shipped.

Share on Social Networks: